Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/348331a0.

Title:
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 | Nature
Description:
THE putative oncogene bcl-2 is juxtaposed to the immunoglobulin heavy chain (Igh) locus1-3 by the t(14;18) chromosomal translocation typical of human follicular B-cell lymphomas4. The bcl-2 gene product (refs 5,6) is not altered by the translocation, but its expression is deregulated6–8, presumably by the Igh enhancer Eµ. Constitutive bcl-2 expression seems to augment cell survival, as infection with a bcl-2 retrovirus enables certain growth factor-dependent mouse cell lines to maintain viability when deprived of factor9,10. Furthermore, high levels of the bcl-2 product can protect human B and T lymphoblasts under stress11,12 and thereby confer a growth advantage12–14. Mice expressing a bcl-2 transgene controlled by the Igh enhancer accumulate small non-cycling B cells which survive unusually well in vitro15–17 but do not show a propensity for spontaneous tumorigenesis15,16. In contrast, an analogous myc transgene, designed to mimic the myc–Igh translocation product typical of Burkitt
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Social Networks
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🚀🌠 Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 19,927,269 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$251,100 per month
Our calculations suggest that Nature.com earns between $167,431 and $460,435 monthly online from display advertisements.

Keywords {🔍}

article, google, scholar, cas, nature, cell, bcl, ads, access, content, mice, cory, proc, natn, acad, sci, usa, cookies, harris, croce, privacy, myc, strasser, oncogene, lymphoma, tsujimoto, pubmed, data, lymphoid, tumours, cells, open, molec, biol, immun, research, advertising, information, subscribe, primitive, transgenic, bath, igh, translocation, bcell, product, growth, preb, institution, buy,

Topics {✒️}

nature portfolio permissions reprints medical research privacy policy advertising subscribe nature social media nature 335 nature 318 nature 324 nature 348 nature lymphoid-committed stem cell springerlink instant access personal data data protection permissions diffuse large eµ–myc mice igh enhancer eµ privacy analogous myc transgene primitive haemopoietic cell chromosomal translocation typical lymphoid cell proliferation lymphoma article strasser augment cell survival explore content subscription content bcl-2 andreas strasser european economic area immunoglobulin heavy chain burkitt' institutional subscriptions read eliza hall institute royal melbourne hospital bcl-2 gene product accepting optional cookies bcl-2 retrovirus enables bcl-2 transgene controlled bcl-2 protein family journals search log issue learn doubly transgenic mice manage preferences access article purchase constitutive bcl-2 expression content

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
         description:THE putative oncogene bcl-2 is juxtaposed to the immunoglobulin heavy chain (Igh) locus1-3 by the t(14;18) chromosomal translocation typical of human follicular B-cell lymphomas4. The bcl-2 gene product (refs 5,6) is not altered by the translocation, but its expression is deregulated6–8, presumably by the Igh enhancer Eµ. Constitutive bcl-2 expression seems to augment cell survival, as infection with a bcl-2 retrovirus enables certain growth factor-dependent mouse cell lines to maintain viability when deprived of factor9,10. Furthermore, high levels of the bcl-2 product can protect human B and T lymphoblasts under stress11,12 and thereby confer a growth advantage12–14. Mice expressing a bcl-2 transgene controlled by the Igh enhancer accumulate small non-cycling B cells which survive unusually well in vitro15–17 but do not show a propensity for spontaneous tumorigenesis15,16. In contrast, an analogous myc transgene, designed to mimic the myc–Igh translocation product typical of Burkitt's lymphoma and rodent plasmacytoma18, promotes B lymphoid cell proliferation and predisposes mice to malignancy in pre-B and B lymphoid cells19-22. Previous experiments have suggested that bcl-2 can cooperate with deregulated myc to improve in vitro growth of pre-B and B cells9,11. Here we describe a marked synergy between bcl-2 and myc in doubly transgenic mice. Eµ–bcl–2/myc mice show hyperproliferation of pre-B and B cells and develop tumours much faster than Eµ–myc mice. Surprisingly, the tumours derive from a cell with the hallmarks of a primitive haemopoietic cell, perhaps a lymphoid-committed stem cell.
         datePublished:
         dateModified:
         pageStart:331
         pageEnd:333
         sameAs:https://doi.org/10.1038/348331a0
         keywords:
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
         isPartOf:
            name:Nature
            issn:
               1476-4687
               0028-0836
            volumeNumber:348
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andreas Strasser
               affiliation:
                     name:Post Office, Royal Melbourne Hospital
                     address:
                        name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alan W. Harris
               affiliation:
                     name:Post Office, Royal Melbourne Hospital
                     address:
                        name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mary L. Bath
               affiliation:
                     name:Post Office, Royal Melbourne Hospital
                     address:
                        name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suzanne Cory
               affiliation:
                     name:Post Office, Royal Melbourne Hospital
                     address:
                        name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
      description:THE putative oncogene bcl-2 is juxtaposed to the immunoglobulin heavy chain (Igh) locus1-3 by the t(14;18) chromosomal translocation typical of human follicular B-cell lymphomas4. The bcl-2 gene product (refs 5,6) is not altered by the translocation, but its expression is deregulated6–8, presumably by the Igh enhancer Eµ. Constitutive bcl-2 expression seems to augment cell survival, as infection with a bcl-2 retrovirus enables certain growth factor-dependent mouse cell lines to maintain viability when deprived of factor9,10. Furthermore, high levels of the bcl-2 product can protect human B and T lymphoblasts under stress11,12 and thereby confer a growth advantage12–14. Mice expressing a bcl-2 transgene controlled by the Igh enhancer accumulate small non-cycling B cells which survive unusually well in vitro15–17 but do not show a propensity for spontaneous tumorigenesis15,16. In contrast, an analogous myc transgene, designed to mimic the myc–Igh translocation product typical of Burkitt's lymphoma and rodent plasmacytoma18, promotes B lymphoid cell proliferation and predisposes mice to malignancy in pre-B and B lymphoid cells19-22. Previous experiments have suggested that bcl-2 can cooperate with deregulated myc to improve in vitro growth of pre-B and B cells9,11. Here we describe a marked synergy between bcl-2 and myc in doubly transgenic mice. Eµ–bcl–2/myc mice show hyperproliferation of pre-B and B cells and develop tumours much faster than Eµ–myc mice. Surprisingly, the tumours derive from a cell with the hallmarks of a primitive haemopoietic cell, perhaps a lymphoid-committed stem cell.
      datePublished:
      dateModified:
      pageStart:331
      pageEnd:333
      sameAs:https://doi.org/10.1038/348331a0
      keywords:
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
      isPartOf:
         name:Nature
         issn:
            1476-4687
            0028-0836
         volumeNumber:348
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andreas Strasser
            affiliation:
                  name:Post Office, Royal Melbourne Hospital
                  address:
                     name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alan W. Harris
            affiliation:
                  name:Post Office, Royal Melbourne Hospital
                  address:
                     name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mary L. Bath
            affiliation:
                  name:Post Office, Royal Melbourne Hospital
                  address:
                     name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suzanne Cory
            affiliation:
                  name:Post Office, Royal Melbourne Hospital
                  address:
                     name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature
      issn:
         1476-4687
         0028-0836
      volumeNumber:348
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Post Office, Royal Melbourne Hospital
      address:
         name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
         type:PostalAddress
      name:Post Office, Royal Melbourne Hospital
      address:
         name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
         type:PostalAddress
      name:Post Office, Royal Melbourne Hospital
      address:
         name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
         type:PostalAddress
      name:Post Office, Royal Melbourne Hospital
      address:
         name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andreas Strasser
      affiliation:
            name:Post Office, Royal Melbourne Hospital
            address:
               name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
               type:PostalAddress
            type:Organization
      name:Alan W. Harris
      affiliation:
            name:Post Office, Royal Melbourne Hospital
            address:
               name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
               type:PostalAddress
            type:Organization
      name:Mary L. Bath
      affiliation:
            name:Post Office, Royal Melbourne Hospital
            address:
               name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
               type:PostalAddress
            type:Organization
      name:Suzanne Cory
      affiliation:
            name:Post Office, Royal Melbourne Hospital
            address:
               name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
               type:PostalAddress
            type:Organization
PostalAddress:
      name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
      name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
      name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
      name:The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria, Australia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(105)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.59s.